Categories News Press Releases Archives 2025 April March February January 2024 December November October September August July June May April March February January 2023 December November October September August July June April March February January 2022 December November October September August July June May April March February January 2021 December November October September August May April February Jan 20 Employee Spotlight: Ian Crassweller – Leading and Evolving Through Change Read More Share:| | Jan 18 Annals of the Rheumatic Diseases Publishes Results from Two Bimekizumab Phase 3 Studies in Axial Spondyloarthritis Read More Share:| | Jan 17 5 U.S. Organizations Receive Support from UCB Community Health Fund Read More Share:| | Jan 06 UCB announces rozanolixizumab BLA for the treatment of generalized myasthenia gravis filed with U.S. FDA and designated for Priority Review Read More Share:| |